This inventor holds 1 USPTO granted patent. Top assignees: Genesis Biologics Holdings Ltd., Healeon Medical Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: A Jason Mirabito: Innovator in Medical Technology
Introduction
A Jason Mirabito is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of medical technology, particularly in the preparation and administration of blood components. His innovative approach has led to the development of a unique dual chambered syringe.
Latest Patents
Mirabito holds a patent for an "Apparatus and method for the preparation and administration of blood components." This invention features a dual chambered syringe that includes an inner barrel with a first inner chamber, an apertured stopper, and a shaft designed to engage with the stopper. The outer barrel is concentric with the inner barrel and defines a second inner chamber, allowing for the controlled passage of fluids. This design enhances the efficiency and safety of blood component administration.
Career Highlights
Throughout his career, A Jason Mirabito has worked with several prominent companies in the medical field. He has been associated with Healeon Medical Ltd. and Genesis Biologics Holdings Ltd., where he has contributed his expertise in medical device innovation. His work has been instrumental in advancing technologies that improve patient care.
Collaborations
Mirabito has collaborated with talented professionals in the industry, including Omer Peled and Shada Abu Hattum. These collaborations have fostered a creative environment that encourages innovation and the development of cutting-edge medical solutions.
Conclusion
A Jason Mirabito's contributions to medical technology, particularly through his patented dual chambered syringe, exemplify his commitment to improving healthcare. His work continues to influence the field and enhance the administration of blood components.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile